secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-08-21T20:50:49+00:00
Accession:  0001213900-26-092651
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies enters $75M ATM equity offering with Jefferies LLC
---------------------------------------------------------------

- On Aug 21, 2026, OS Therapies (OSTX) entered an Open Market Sale Agreement with Jefferies LLC.
- Company may sell up to $75 million of common stock via at-the-market offering under Form S-3.
- Jefferies earns 3.0% commission on gross proceeds; up to $100,000 in legal fee reimbursements.
- Net proceeds to fund clinical trials, R&D programs, and potential complementary acquisitions.
- Offering terminates when all shares sold or upon 10 days' notice from either party.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026092651/0001213900-26-092651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026092651/ea0303019-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-092651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer